Repare Therapeutics Inc (RPTX)
3.57
+0.04
(+1.13%)
USD |
NASDAQ |
May 17, 16:00
3.57
0.00 (0.00%)
After-Hours: 20:00
Repare Therapeutics Profit Margin (Quarterly): 25.12% for March 31, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 25.12% |
| December 31, 2023 | -214.8% |
| September 30, 2023 | -874.4% |
| June 30, 2023 | -39.49% |
| March 31, 2023 | -615.4% |
| December 31, 2022 | -174.0% |
| September 30, 2022 | 67.05% |
| Date | Value |
|---|---|
| June 30, 2022 | -5.61K% |
| March 31, 2022 | -8.52K% |
| December 31, 2021 | -411.4% |
| September 30, 2021 | -11.11K% |
| June 30, 2021 | -9.43K% |
| March 31, 2021 | -12.90K% |
| December 31, 2020 | -11.31K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-12.90K%
Minimum
Mar 2021
67.05%
Maximum
Sep 2022
-4.37K%
Average
-744.9%
Median
Profit Margin (Quarterly) Benchmarks
| Acasti Pharma Inc | -- |
| Aurinia Pharmaceuticals Inc | -59.60% |
| Edesa Biotech Inc | -- |
| Lexaria Bioscience Corp | -448.0% |
| InMed Pharmaceuticals Inc | -146.9% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -19.46% |
| Return on Assets | -15.85% |
| Return on Invested Capital | -19.46% |
| Operating Margin (Quarterly) | 20.64% |
| Return on Net Operating Assets | -58.99% |